Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
28.34
-1.52 (-5.09%)
At close: May 30, 2025, 4:00 PM
29.99
+1.65 (5.82%)
After-hours: May 30, 2025, 7:55 PM EDT

Tvardi Therapeutics Stock Forecast

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Tvardi Therapeutics stock ranges from a low of $39 to a high of $65. The average analyst price target of $52 forecasts a 83.49% increase in the stock price over the next year.

Price Target: $52.00 (+83.49%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $39 $52 $65 $65
Change +37.61% +83.49% +129.36% +129.36%

Analyst Ratings

The average analyst rating for Tvardi Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '25
Strong Buy 1
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 2

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Oppenheimer
Oppenheimer
Buy
Initiates
$65
Buy Initiates $65 +129.36% May 21, 2025
Jones Trading
Jones Trading
Strong Buy
Initiates
$39
Strong Buy Initiates $39 +37.61% Apr 28, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock

Revenue Forecast

Revenue 201920202021202220232024202520262027
High 23.0M 141.7M 31.6M
Avg 20.5M 67.0M 23.8M
Low 14.9M 24.8M 21.6M

Revenue Growth

Revenue Growth 20202021202220232024202520262027
High
590.6%
-52.9%
150.7%
Avg
226.7%
-64.5%
129.2%
Low
20.7%
-67.8%
87.9%

EPS Forecast

EPS 201920202021202220232024202520262027
High -86.18 8.69 -57.83
Avg -93.72 -44.66 -58.90
Low -96.31 -81.50 -61.03

EPS Growth

EPS Growth 20202021202220232024202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.